Among individuals never diagnosed with IM, there was nearly tenfold odds variation between HLA-A*01 and HLA-A*02 homozygotes in risk of EBV-related HL (OR 9.45, 95% CI 4.6–19.4). The gene discussed is HLA-A; the disease is Hodgkins lymphoma.